A study of the Effects of Inhaled Fliticasone Furotate/GW642444 versus Placebo on HPA Axis of Adolescent and Adult Asthmatics

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-017669-44

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to assess the effect of six weeks’ treatment with two once-daily strengths of Fluticasone Fuorate /GW642444 Inhalation Powder on the hypothalamic-pituitary-adrenal (HPA) axis system compared with placebo. A 7-day course of oral prednisolone is included as an active control to ensure the assay is sufficiently sensitive to detect a drug effect.


Critère d'inclusion

  • Adolescent (12-17 years) and Adult Asthmathics